Arena Pharmaceuticals, Inc. (ARNA)

ARNA was initiated with a Buy and price target of $9.00 by brokerage firm WallachBeth.

ARNA closed at $5.46, up $0.35 (or +6.83%) .

ARNA is a biopharmaceutical company focused on discovering, developing and commercializing novel-drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.

More about Arena Pharmaceuticals, Inc. (ARNA) at www.arenapharm.com .

**

Crown Equity Holdings Inc. (CRWE)

CRWE is looking to deliver value for its stockholders in both the near and long term, and to improve the potential future growth for the company, CRWE is targeting the multi-billion dollar B2B (business to business) and online video-sharing markets.

Strategic plans are being developed for CRWE ’s Division CRWETube ( www.crwetube.com ) and its iB2B Global project.

As a worldwide online multi-media publisher, CRWE ‘s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. The company launches, invests and manages select businesses, projects and real estate endeavors.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com .

**

InterCloud Systems, Inc. (ICLD)

ICLD jumped $6.91 (or +270.97%) to $9.46 on Friday, after the company reported strong performance in revenue on its financial results

For the third quarter 2013, ICLD posted revenue of $16.2 million, an increase of 448% year over year, gross profit of $5.5 million, compared to $1.2 million in the same period the prior year, and net income of $1.3 million, or $0.26 basic earnings per share, and $0.12 diluted earnings per share, compared to a net loss of $0.8 million, or ($2.16) per share, in the third quarter of 2012.

ICLD is a global single-source provider of value-added IT and telecom solutions for both corporate enterprises and service providers.

More about InterCloud Systems, Inc. (ICLD) at www.intercloudsys.com .

**

FONAR Corp. (FONR)

Shares of FONR soared $6.31 (or +59.03%) to $17.00 on Friday's trading session, after the company reported a large increase in total revenues and diluted earnings per share available for the common stockholder on its financial results, compared to one year earlier.

On its first quarter fiscal 2014, FONR posted net revenue of $16.8 million, a 77% increase year over year, income from operations of $4.0 million, compared to $1.9 million in the same period the prior year, and diluted earnings per share available for the common stockholder of $0.37, increased 68% compared to the same period one year earlier.

FONR is engaged in the design, manufacture, sale, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, injuries, and other medical conditions

More about FONAR Corp. (FONR) at www.fonar.com

**

Read Full Disclaimer at www.drstockpick.com/disclaimer